Hikma Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:H5P Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
09 Aug 24	Sell€1,035,608	Bassam Wael Kanaan	Individual		45,000	€23.67

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of H5P?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	43,000	0.0194%
State or Government	85,472	0.0385%
Employee Share Scheme	564,924	0.255%
Individual Insiders	4,581,208	2.07%
General Public	31,673,127	14.3%
Private Companies	60,796,697	27.4%
Institutions	124,003,147	55.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.24% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
27.1%	Darhold Ltd.	60,000,000	€1.7b	0%	no data
5.8%	BlackRock, Inc.	12,867,816	€360.1m	-9.73%	0.01%
3.52%	The Vanguard Group, Inc.	7,813,083	€218.7m	1.14%	no data
2.14%	Bank Julius Bär & Co Ltd., Asset Management Arm	4,740,672	€132.7m	-0.05%	0.37%
1.85%	Baillie Gifford & Co.	4,111,374	€115.1m	59.9%	0.05%
1.82%	Mawer Investment Management Ltd.	4,041,166	€113.1m	-10.4%	0.26%
1.42%	Employees Provident Fund of Malaysia	3,138,515	€87.8m	0%	0.21%
1.41%	Invesco Ltd.	3,130,725	€87.6m	97.6%	0.02%
1.38%	Royal London Asset Management Ltd.	3,064,175	€85.8m	-7.11%	0.11%
1.34%	Columbia Management Investment Advisers, LLC	2,981,189	€83.4m	17%	0.02%
1.29%	Boston Partners Global Investors, Inc.	2,857,995	€80.0m	-25.5%	0.05%
1.24%	Jupiter Fund Management Plc	2,760,560	€77.3m	2.56%	0.24%
1.24%	Polar Capital Holdings Plc	2,756,621	€77.2m	0%	0.27%
1.1%	Amundi Asset Management SAS	2,432,787	€68.1m	5.44%	0.01%
1.05%	Norges Bank Investment Management	2,334,376	€65.3m	23.9%	0.01%
1.05%	State Street Global Advisors, Inc.	2,321,229	€65.0m	-0.4%	no data
1.03%	Legal & General Investment Management Limited	2,282,876	€63.9m	2.14%	0.01%
1%	HSBC Global Asset Management (UK) Limited	2,214,033	€62.0m	-9.5%	0.03%
0.91%	AllianceBernstein L.P.	2,025,783	€56.7m	315%	0.02%
0.82%	Fidelity International Ltd	1,828,120	€51.2m	7.7%	0.02%
0.82%	Dimensional Fund Advisors LP	1,811,879	€50.7m	-0.3%	0.01%
0.82%	GIC Private Limited	1,808,317	€50.6m	-2.88%	0.1%
0.71%	Goldman Sachs Group, Investment Banking and Securities Investments	1,581,319	€44.3m	106%	0.02%
0.71%	Van Lanschot Kempen Investment Management N.V.	1,575,608	€44.1m	2.16%	0.3%
0.69%	American Century Investment Management Inc	1,531,343	€42.9m	9.58%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 20:55
End of Day Share Price	2025/02/18 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hikma Pharmaceuticals PLC is covered by 37 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kamla Singh	AlphaValue
Simon Mather	Barclays
Emily Field	Barclays